Inhibition of human parainfluenza virus-3 replication by interferon and human MxA

Virology

Volumn 220, Issue 2, 1996, Pages 330-338

  Zhao, Hong ^b   De, Bishnu P ^a   Das, Tapas ^a   Banerjee, Amiya K ^a,b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; MYXOVIRUS RESISTANCE PROTEIN A; PROTEIN; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; PARAINFLUENZA VIRUS 3; PRIORITY JOURNAL; VIRUS INHIBITION; VIRUS REPLICATION;

HUMAN PARAINFLUENZA VIRUS 3; RNA VIRUSES;

EID: 0029894718     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1996.0321     Document Type: Article

References (38)

1. Aebi, M., Fah, J., Hurt, N., Samuel, C. E., Thomis, D., Bazzigher, L., Pavlovic, J., Haller, Q., and Staeheli, P. (1989). cDNA structures and regulation of two interferon-induced human Mx proteins. Mol. Cell. Biol. 9, 5062-5072.
2. Banerjee, A. K., Barik, S., and De, B. P. (1991). Gene expression of nonsegmented negative strand RNA viruses. Pharmac. Ther. 51, 47-70.
3. Barik, S., and Banerjee, A. K. (1991). Cloning and expression of the vesicular stomatitis virus phosphoprotein gene in Escherichia coli: Analysis of phosphorylation status versus transcriptional activity. J. Virol. 65, 1719-1726.
4. Belkowski, L. S., and Sen, G. C. (1987). Inhibition of vesicular stomatitis viral mRNA synthesis by interferons. J. Virol. 61, 653-660.
5. Cantell, K. (1995). Development of antiviral therapy with alpha interferons: Promises, false hopes, and accomplishments. Anal. Med. 27, 23-28.
6. Chanock, R M., and McIntosh, K. (1990). Parainfluenza viruses. "Virology" (B. N. Fields, Ed.), pp. 963-988. Raven Press, New York.
7. Chebath, J., Benech, P., Revel, M., and Vigneron, M. (1987). Constitutive expression of (2′-5′) oligo A synthetase confers resistance to picornavirus infection. Nature 330, 587-588.
8. Chomczynski, P., and Sacchi, N. (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159.
9. Coccia, E. M., Romeo, G., Nissim, A., Marziali, G., Albertini, R., Affabris, E., Battistini, A., Fiorucci, G., Orsatti, R., Rossi, G. B., and Chebath, J. (1990). A full-length murine 2-5A synthetase cDNA transfected in NIH-3T3 cells impairs EMCV but not VSV replication. Virology 179, 228-233.
10. Das, T., De, B. P., and Banerjee, A. K. (1996). Expression, purification, and characterization of Rhabdovirus polymerase. Methods Enzymol., in press.
11. De, B. P., Gupta, S., Gupta, S., and Banerjee, A. K. (1995). Cellular protein kinase C ζ regulates human parainfluenza virus type 3 replication. Proc. Natl. Acad. Sci. USA 92, 5204-5208.
12. Glezen, W. P., Frank, A. L., Taber, L. H., and Kasel, J. A. (1984). Parainfluenza virus type 3: Seasonality and risk of infection and reinfection in young children. J. Infect. Dis. 150, 851-857.
13. Hayden, F. G. (1988). Interanasal interferons for control of respiratory viral infections. "Clinical Aspects of Interferons" (M. Revel, Ed.), pp. 3-16. Kluwer Academic, Boston.
14. Horisberger, M. A., McMaster, G. K., Zeller, H., Wathelet, M. G., Dellis, J, and Content, J. (1990). Cloning and sequence analyses of cDNAs for Interferon- and virus-induced human Mx proteins reveal that they contain putative guanine nucleotide-binding sites: Functional study of the corresponding gene promoter. J. Virol. 64, 1171-1181.
15. Horisberger, M. A. (1992). Interferon-induced human protein MxA is a GTPase which binds transiently to cellular proteins. J. Virol. 66, 4705-4709.
16. Kerr, I. M., and Stark, G. R. (1992). The antiviral effects of the interferons and their inhibition. J. IFN Res. 12, 237-240.
17. Kumar, R., Chattopadhyay, D., Banerjee, A. K., and Sen, G. C. (1988). Rbonuclease activity is associated with subviral particles isolated from interferon-treated vesicular stomatitis virus-infected cells. J. Virol. 62, 641-643.
18. Landolfo, S., Gribaudo, G., Angeretti, A., and Gariglio, M. (1995). Mechanisms of viral inhibition by interferons. Pharmacol. Ther. 65, 415-442.
19. Lengyel, P. (1987). Double-stranded RNA and their actions. J. IFN Res. 7, 511-519.
20. Lindenmann, J. (1962). Resistance of mice to mouse adapated influenza A virus. Virology 16, 203-204.
21. Marcus, P. I., and Sekellik, M. J. (1978). Interferon action III. The rate of primary transcription of vesicular stomatitis virus is inhibited by Interferon action. J. Gen. Virol. 38, 391-408.
22. Masters, P. S., and Samuel, C. E. (1983). Mechanism of Interferon action: Inhibition of vesicular stomatitis virus replication in human amnion U cells by cloned human leukocyte Interferon. J. Biol. Chem. 258, 12026-12033.
23. Mathews, M. G., and Shenk, T. (1991). Adenovirus virus-associated RNA and translation control. J. Virol. 65, 5657-5662.
24. McNair, A. N. B., and Kerr, I. M. (1992). Viral inhibition of the Interferon system. Pharmacol. Ther. 56, 79-95.
25. Meurs, E. F., Watanabe, Y., Kadereit, S., Barber, G. N., Katze, M. G., Chong, K., Williams, B. R. G., and Hovanessian, A. G. (1992). Constitutive expression of human double-stranded RNA-activated p68 kinase in murine cells mediates phosphorylation of eukaryotic initiation factor 2 and partial resistance to encephalomyocarditis virus growth. J. Virol. 66, 5805-5814.
26. Muller, U., Steinhoff, U., Reis, L F. L., Hemmi, S., Pavlovic, J., Zinkernagel, R M., and Aguet, M. (1994). Functional role of type I and type II interferons in antiviral defense. Science 264, 1918-1921.
27. Obar, R. A., Collins, C. A., Hammarback, J. A., Shpetner, H. S., and Vallee, R. B. (1990). Molecular cloning of the microtubule-associated mechanochemical enzyme dynamin reveals homology with a new family of GTP-binding proteins. Nature 347, 256-261.
28. Pavlovic, J., Zurcher, T., Haller, O., and Steheli, P. (1990). Resistance to influenza virus and vesicular stomatitis virus conferred by expression of human MxA protein. J. Virol. 64, 3370-3375.
29. Pavlovic, J., and Staeheli, P. (1991). The antiviral potentials of Mx proteins. J. IFN Res. 11, 215-219.
30. Rysiecki, G., Gewert, D. R., and Williams, B. R. G. (1989). Constitutive expres-sion of a 2′,5′-oligoadenylate synthetase cDNA results in increased antiviral activity and growth suppression. J. IFN Res. 9, 649-657.
31. Samuel, C. E. (1991). Minireview. Antiviral actions of Interferon. Interferon-regulated cellular proteins and their surprisingly selective antiviral activities. Virology 183, 1-11.
32. Schneider-Schaulies, S., Schneider-Schaulies, J, Schuster, A., Bayer, M., Pavlovic, J., and Meulen, V. T. (1994). Cell type-specific MxA-mediated inhibition of measles virus transcription in human brain cells. J. Virol. 68, 6910-6917.
33. Schnorr, J., Schneider-Schaulies, S., Simon-Jodicke, A., Pavlovic, J., Horisberger, M. A., and Meulen, V. T. (1993). MxA-dependent inhibition of measles virus glycoprotein synthesis in a stably transfected human monocytic cell line. J. Virol. 67, 4760-4768.
34. Schwemmle, N., Weining, K. C., Richter, M. F., Schumacher, B., and Staeheli, P. (1995). Vesicular stomatitis virus transcription inhibited by purified MxA protein. Virology 206, 545-554.
35. Sen, G. C., and Lengyel, P. (1992). The Interferon system. A bird's eye view of its biochemistry. J Bol. Chem. 267, 5017-5020.
36. Staeheli, P. (1990). Interferon-induced proteins and the antiviral state. Adv. Virus Res. 38, 147-248.
37. Staeheli, P., and Pavlovic, J. (1991). Inhibition of vesicular stomatitis virus mRNA synthesis by human MxA protein. J. Virol. 65, 4498-4501.
38. Wechsler, S. L., Lambert, D. M., Galinski, M. S., Heineke, B. E., Lambert, A. L., Mink, M., Rochovansky, O. M., and Pons, M. W. (1985). A simple method for increased recovery of purified paramyxovirus virions. J. Virol. Methods 12, 179-182.